Načítá se...

Five-year safety and performance results from the Argus II Retinal Prosthesis System clinical trial

PURPOSE: The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA) was developed to restore some vision to patients blind from retinitis pigmentosa (RP) or outer retinal degeneration. A clinical trial was initiated in 2006 to study the long-term safety and efficacy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ophthalmology
Hlavní autoři: da Cruz, Lyndon, Dorn, Jessy D., Humayun, Mark S., Dagnelie, Gislin, Handa, James, Barale, Pierre-Olivier, Sahel, José-Alain, Stanga, Paulo E., Hafezi, Farhad, Safran, Avinoam B., Salzmann, Joel, Santos, Arturo, Birch, David, Spencer, Rand, Cideciyan, Artur V., de Juan, Eugene, Duncan, Jacque L., Eliott, Dean, Fawzi, Amani, Olmos de Koo, Lisa C., Ho, Allen C., Brown, Gary, Haller, Julia, Regillo, Carl, Del Priore, Lucian V., Arditi, Aries, Greenberg, Robert J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035591/
https://ncbi.nlm.nih.gov/pubmed/27453256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.06.049
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!